Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 3/20 | 0.41 |
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.35 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.35 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.33 |
| ▸ | HTR3B | O95264 | 1/20 | 0.33 |
| ▸ | HTR3A | P46098 | 1/20 | 0.33 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.33 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL971806 | 0.83 | HSD17B10 (0.46) | HSD17B10TTRAHRTP53TSHR | |
| SCHEMBL26263783 | 0.83 | TTR (0.38) | HSD17B10TTRAHRTP53TSHR | |
| SCHEMBL3016981 | 0.83 | TTR (0.38) | HSD17B10TTRAHRTP53TSHR | |
| SCHEMBL130450 | 0.78 | TTR (0.61) | HSD17B10TTRAHRTP53TSHR | |
| SCHEMBL12050460 | 0.74 | HSD17B10 (0.42) | HSD17B10TTRAHRTP53TSHR | |
| SCHEMBL19712647 | 0.73 | ENPP2 (0.59) | TSHRCYP3A4ENPP2ORAI1ORAI2 | |
| SCHEMBL7085519 | 0.70 | TTR (0.52) | HSD17B10TTRAHRTP53ENPP2 | |
| SCHEMBL21913496 | 0.69 | AHR (0.43) | HSD17B10TTRAHRTP53TSHR | |
| SCHEMBL19712775 | 0.68 | ORAI1 (0.41) | ENPP2ORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL19712771 | 0.68 | ORAI1 (0.36) | ORAI1ORAI2ORAI3TRPV6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| WO-2025120994-A1 | SECONDARY BATTERY NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY PROVIDED WITH SAME | ステラケミファ株式会社 | 2025-06-12 | — | — | WO | disclosed |
| US-12191448-B2 | Nonaqueous electrolyte solution for secondary battery, and secondary battery provided with said solution | STELLA CHEMIFA CORPORATION (JP) | 2025-01-07 | — | — | US | disclosed |
| EP-4428982-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023079988-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | 国立大学法人京都大学 | 2023-05-11 | — | — | WO | disclosed |
| US-20210202991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION | STELLA CHEMIFA CORPORATION (JP) | 2021-07-01 | — | — | US | disclosed |
| US-11005125-B2 | Nonaqueous electrolyte solution for secondary batteries and secondary battery provided with same | STELLA CHEMIFA CORPORATION (JP) | 2021-05-11 | — | — | US | disclosed |
| EP-3396768-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED THEREWITH | STELLA CHEMIFA CORP (JP) | 2020-04-22 | — | — | EP | disclosed |
| EP-3396768-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION | Stella Chemifa Corporation (JP) | 2018-10-31 | — | — | EP | disclosed |
| US-20180301756-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | STELLA CHEMIFA CORP (JP) | 2018-10-18 | — | — | US | disclosed |
| EP-3309890-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | Stella Chemifa Corporation (JP) | 2018-04-18 | — | — | EP | disclosed |
| US-20180034102-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | STELLA CHEMIFA CORP (JP) | 2018-02-01 | — | — | US | disclosed |
| US-20180026303-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | STELLA CHEMIFA CORP (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20180019498-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | STELLA CHEMIFA CORPORATION (JP) | 2018-01-18 | — | — | US | disclosed |
| EP-3258531-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | Stella Chemifa Corporation (JP) | 2017-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11005125-B2 | Nonaqueous electrolyte solution for secondary batteries and secondary battery provided with same | CA12, CA2, CA1 | HSD17B10 675/4885TTR 4284/4885AHR 4329/4885 |
| US-20180019498-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME | CA12, CA2, CA1 | HSD17B10 675/4885TTR 4284/4885AHR 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.